News stories

How will Brexit affect the supply and availability of meningitis vaccines?

Paul Gentry, who lost his daughter Izzy in May 2016, met with Bristol East MP Kerry McCarthy

One year ago, as the MenB vaccine debates were taking place, we continued to hear distressing stories where any Government change of heart to introduce the vaccine to all children would come too late

Meningitis Now has today expressed concerns that parents may refuse to get their children immunised with the meningococcal B vaccine (Men B) following the moving case of baby Bobby Maguire

Students at London University have produced a film report on the recent MenB vaccine petition and the Government’s response

GSK has today confirmed that stocks of Bexsero, the Men B vaccine, will be available for use in the private clinic sector from June

In response to yesterday’s parliamentary debate to extend the meningococcal B (Men B) vaccine Meningitis Now CEO Liz Brown said:

Today's debate directly reflects the concerns of the 820,000 people who read the Faye Burdett story and signed the biggest ever parliamentary petition to prevent another child suffering or dying from this devastating disease

Following the second of the two evidence sessions on extending the use of the Men B vaccine recently, a date has now been set for MPs to debate this.

Parliament set date to debate Men B petition

Charities announce 10-Point Action Plan to protect against meningitis and provide fair access to lifesaving vaccines

The first of the two Petitions Committee evidence sessions on extending the use of the Men B vaccine took place today at Portcullis House in Westminster

Meningitis Now will be attending the session on 22 March 2016 and will continue to be the voice for people affected by this devastating disease.

We keenly await information about the process of MPs speaking to families and health experts, prior to a debate in Parliament and will ensure that we continue to be the voice for people affected by meningitis

People can be assured that MenB disease is still a rare disease and people are at no more risk now than they were a few weeks ago. The shortage of the vaccine is likely to continue until the summer

Following huge demand for Men B vaccine, Bexsero, we are aware of a current supply shortage in private clinics

Campaigners across the country are today celebrating the roll out of a lifesaving vaccine for deadly meningococcal group B (Men B) disease, a common cause of meningitis

Second anniversary and still no vaccine, in that time some 24 UK children under one – one a month – could have died of the disease.

We are delighted that the UK’s first Meningitis B vaccine will be swiftly rolled out after price negotiations resolve